SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED

Dissolved London

Other research and experimental development on natural sciences and engineering

Other research and experimental development on natural sciences and engineering
S

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED

Other research and experimental development on natural sciences and engineering

Founded 29 Mar 1990 Dissolved London, United Kingdom website.com
Other research and experimental development on natural sciences and engineering

Previous Company Names

ROCHGRANGE LIMITED 29 Mar 1990 — 31 Aug 1990
Accounts Submitted 19 May 2022
Confirmation Submitted 4 Jul 2022 Next due 12 Jul 2023 35 months overdue
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges 2
2 satisfied

Contact & Details

Contact

Registered Address

1 Kingdom Street London W2 6BD United Kingdom

Full company profile for SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED (02486738), a dissolved company based in London, United Kingdom. Incorporated 29 Mar 1990. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

No accounts filed yet

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Takeda Corporate Services LimitedCorporate-secretaryUnited KingdomUnknown1 Mar 2018Active

Shareholders

Shareholders (1)

Shire Pharmaceuticals Group
100.0%
230,610,990

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED Current Company

Charges

Charges

2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Mar 2023GazetteGazette Dissolved Voluntary
3 Jan 2023GazetteGazette Notice Voluntary
22 Dec 2022DissolutionDissolution Application Strike Off Company
10 Nov 2022OfficersTermination of Mark Gibbons as director on 8 Nov 2022
4 Jul 2022Confirmation StatementConfirmation statement made on 28 Jun 2022 with updates
21 Mar 2023 Gazette

Gazette Dissolved Voluntary

3 Jan 2023 Gazette

Gazette Notice Voluntary

22 Dec 2022 Dissolution

Dissolution Application Strike Off Company

10 Nov 2022 Officers

Termination of Mark Gibbons as director on 8 Nov 2022

4 Jul 2022 Confirmation Statement

Confirmation statement made on 28 Jun 2022 with updates

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

3 years ago on 21 Mar 2023

Gazette Notice Voluntary

3 years ago on 3 Jan 2023

Dissolution Application Strike Off Company

3 years ago on 22 Dec 2022

Termination of Mark Gibbons as director on 8 Nov 2022

3 years ago on 10 Nov 2022

Confirmation statement made on 28 Jun 2022 with updates

3 years ago on 4 Jul 2022